March/April 2024

Featured Article

Editor's Page

Patient-Centric Care in Precision Medicine: Overcoming Barriers, Embracing Innovation

03/27/2024

Winston Wong, PharmD, Editor-in-Chief

Editor-in-Chief Winston Wong, PharmD, provides insights on this issue’s content, including current trends in the utilization of biomarker testing and patient-reported outcome measures.

Editor-in-Chief Winston Wong,...

03/27/2024

Journal of Clinical Pathways

Column

Transformative Employer Trends

Shared Decision-Making on Health Care Risks

03/27/2024

F. Randy Vogenberg, PhD, FASHP

This column explores the purpose behind managing risk and determining how conflict around care cost management can occur, including through the use of pathways.

This column explores the purpose...

03/27/2024

Journal of Clinical Pathways

MAI Mindset

December 2023 Pathways Impact Study Part 2: Impact of Pathway Programs on Treatment Selection

03/27/2024

Lee Blansett, MBA

This entry of our MAI Mindset column summarizes the second part of a study by HMP Market Access Insights, which examined the influence and impact pathways have on oncologists’ treatment decisions.

This entry of our MAI Mindset...

03/27/2024

Journal of Clinical Pathways

Insights

Interview

Chronic Lymphocytic Leukemia Pathways in Practice at Rocky Mountain Cancer Centers

03/27/2024

John Burke, MD, discusses the current treatment landscape for chronic lymphocytic leukemia and describes how his center ensures a comprehensive approach to patient care.

John Burke, MD, discusses the...

03/27/2024

Journal of Clinical Pathways

Feature

Research Reports

Patient-Reported Outcomes in Hematopoietic Stem Cell Transplant Recipients: Design, Implementation, and Pilot Results

02/21/2024

Christi Ann Hayes, MD

Aricca D. Van Citters, MS

Wenyan Zhao, PhD

Kate L. Caldon

Charlotte M. Coughenour

Tor D. Tosteson, PhD

Anna N. A. Tosteson, PhD

Kenneth R. Meehan, MD

In a recent study, Christi Ann Hayes, MD, and colleagues aimed to define patient-reported outcome measures in patients receiving hematopoietic stem cell transplant.

In a recent study, Christi Ann...

02/21/2024

Journal of Clinical Pathways

From the Field

Comprehensive Genomic Testing: Tissue Stewardship and Best Practices

02/12/2024

Rebecca A. Previs, MD, MS

Maureen E. Cooper, BS

Kyle C. Strickland, MD

Heidi Ko, DO

Michelle F. Green, PhD

Faezeh Koohestani, PhD

Stephanie Hastings, PhD

Zachary Wallen, PhD

Sarabjot Pabla, PhD

Jeffrey M. Conroy, BS

Mary Nesline, MS

Shengle Zhang, MD

Durga Prasad Dash, PhD

Brian Caveney, MD, JD, MPH

Marcia Eisenberg, PhD

Eric Severson, MD, PhD

Shakti H. Ramkissoon, MD, PhD

Rebecca A. Previs, MD, et al provide an overview of current genomic testing methodologies and offer guidelines on best practices for tissue stewardship and preanalytic practices for successful comprehensive genomic profiling.

Rebecca A. Previs, MD, et al...

02/12/2024

Journal of Clinical Pathways

Current Issue

June 2024

Volume 10

Issue 3

Current Issue

Issue Archive

Special Reports

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Winston Wong, PharmD

Gordon Kuntz

Robin T Zon, MD, FACP, FASCO

2021 Care Pathways Working Group

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

$Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma$

Special Report

Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma

01/14/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Editorial Correspondence

March/April 2024

Featured Article

Column

Insights

Feature

Current Issue

Special Reports

Subscribe

April 2024 Volume 10 Issue 2

Specialties

Events

Year Round Education

HMP Global Products